I am crypto trader and personal finance enthusiast I will share everything I know about cryptocurrency Investment in knowledge pays the best interest.
MARS
Joined February 2024
- Tweets18.1K
- Following534
- Followers9K
- Likes25.6K
study bitcoins retweeted
REalloys, $ALOY Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing.
Worth Watching
Paid Disclosure: thetitanmedia.com/disclaimer
stockresearchtoday.com/aloy/
study bitcoins retweeted
$ALOY breakout confirmed
Base built.
Volume 40%+ above average.
Elliott wave (i) done, (ii) held.
Elliott showed WHERE.
O’Neil confirmed WHEN.
Stop: 7-8% below
Targets: $9.4 → $15 → $20+
Patience paid.
Not Financial Advice: Disclaimer thetitanmedia.com/disclaimer
study bitcoins retweeted
Last week, $ALOY was identified as completing its final leg (wave C) of the corrective structure, with a potential Wave 1 beginning a larger trend. Price action is now confirming the transition into a higher-degree trend.
The takeaway is that volume acts like location in real estate. Accumulation at key levels shows where institutional participation is concentrated, and that is where the best risk-reward entries tend to form.
Disclaimer: thetitanmedia.com/
@TheTitanMedia
study bitcoins retweeted
A compelling story doesn’t automatically make a winning stock. $FBDT is a lesson every trader should understand.
Price trend: Is the stock building a
$FBDT has fallen dramatically from its $12 high in August to around $0.76 at the October 20
Means Anything can happen bullish/ bearish but see like A promising Stock to keep on the radar:
Learn direct from: youtube.com/watch?v=E9zxrNXv…
Disclaimer: thetitanmedia.com/disclaimer
@TheTitanMedia
study bitcoins retweeted
What Happened 9/1/2010 on $NASDAQ Composite/index see is going to happen on $ALOY in any big reversal day 1 after the decline look for the market to attempt to rally as seen here a follow through day can occur on 4th day
So Most of the time usually use secondary position entries:
Stop-loss must be tighter 3-5% and less than full sized positions should be taken.
Disclaimer: thetitanmedia.com/disclaimer👇
👇
study bitcoins retweeted
BULLISH CONFIRMATION, CLEAN PRICE ACTION INSIGHT.
Bullish candlestick confirmations are powerful when they appear at demand zones.
Patterns like pin bars, hammers, and engulfing candles show clear rejection and buyer strength, perfect signals for continuation.
✅ Pin Bar — Long wick shows strong rejection and buyer pressure
✅ Hammer — Buyers absorb selling and push price back up
✅ Engulfing — Strong shift in momentum as buyers fully take control
Clean confirmations + demand zones = high‑probability bullish setups.
study bitcoins retweeted
Are you prepared for Earnings Season?
Join superperformance trader @markminervini for a FREE IBD webinar on navigating earnings season using @marketsurge Oct. 14 | 1 p.m. PT
Register for FREE:
webinar.investors.com/regist…
study bitcoins retweeted
One lesson I've learned after years of studying biotech companies: understanding the science matters as much as understanding the chart.
$GTBP
GT Biopharma's TriKE platform is designed to help the body's natural killer (NK) cells identify and attack cancer cells. The technology combines NK cell activation, immune cell expansion through IL-15, and precise tumor targeting in a single construct.
What's especially interesting is that newer-generation TriKEs are reported to be significantly more potent than earlier versions, highlighting how rapidly immunotherapy platforms continue to evolve.
As investors, it's worth understanding the underlying mechanism before focusing on the ticker. Knowledge first, opinions later.
My key level:
1: $7.30
2: $9.69
3:11.98 &Support at $5.80
Disclaimer: thetitanmedia.com/disclaimer
study bitcoins retweeted
One lesson from the $LLY vs. $NVO battle:
Never confuse a growing industry with a winning investment.
Follow the money.
Study the margins.
Watch the competition.
Understand who actually captures the growth.
Because in the stock market, the biggest story isn’t always the best opportunity.
The numbers usually tell a deeper story.
Follow along we’re just getting started.
This quoted post is unavailable.
study bitcoins retweeted
Everyone's talking about 21 presentations from $LLY.
I'm watching one thing:
Zepbound + Taltz in psoriasis patients with obesity.
~61% of plaque psoriasis patients are overweight or obese.
If tirzepatide improves inflammatory and cardiovascular markers beyond Taltz alone, this becomes much bigger than a weight-loss story.
The press release doesn't matter.
The data does.
Can it change how doctors prescribe and how payers cover both therapies together?
That's the difference between interesting science and a multi-billion dollar opportunity.
Oct 8-11 is what matters.
Question for biotech investors: If the data is strong, does this create a new growth leg for $LLY, or is that already fully priced in?
$LLY $NVO $MRK #Biotech #Pharma
I think the more interesting part of $LLY dermatology update has very little to do with the fact they have 21 presentations coming.
Everyone already knows Lilly wants to push Zepbound beyond just weight loss.
What I am watching is what happens when they put it next to Taltz in patients who have both psoriasis and obesity.
At Fall Clinical they are showing biomarker data from TOGETHER-PsO plus an analysis looking at cardiovascular risk factors with Taltz + Zepbound versus Taltz alone.
Thats interesting because obesity and inflammatory disease overlap a lot more than the market usually treats them.
Roughly 61% of plaque psoriasis patients in the US are also classified as overweight or obese.
If losing weight with tirzepatide also changes the inflammatory or cardiovascular profile of these patients beyond what Taltz is already doing, then Zepbound starts becoming useful in a much broader treatment conversation.
But I dont think the press release itself changes much for the stock today.
Lilly already has huge expectations built around expanding tirzepatide into more metabolic and structural diseases.
So for me the bar is not “did the biomarkers move?”
Its whether the actual data is strong enough to change how doctors treat these patients, or eventually how payers think about covering both therapies concomitantly.
Thats what I want to see when the full data comes out Oct 8–11
Interesting biology is one thing Turning it into a highly protected patient pool and more durable commercial revenue is the part that actually matters.
$NVO $MRK #Biotech #Pharma
study bitcoins retweeted
NASDAQ: The index indexes remain in a clear uptrend, gained 1.19% finished just below its record high. If the Nasdaq continues higher and breadth begins improving, that's a very bullish combination.
If the Nasdaq keeps making highs while fewer and fewer stocks participate, I'd become increasingly defensive. The Nasdaq is being supported by a relatively small group of powerful technology/AI stocks.
That's not necessarily bearish. If more growth stocks begin reclaiming their 50-day moving averages and breaking out of proper bases, the current rally becomes much more convincing.
If the Nasdaq continues making new highs while participation keeps deteriorating, the divergence becomes increasingly important
study bitcoins retweeted
$MRNA has gone from a beaten-down post-COVID story to a stock up over 500% YTD.
Its return to the Nasdaq-100 on October 9 could trigger passive fund buying, but the bigger question is what happens after those flows fade.
With Citi downgrading the stock to Sell over pipeline valuation concerns, all eyes now turn to October 24 and Moderna’s oncology data at ESMO.
The real test: Is this rally driven by positioning and liquidity, or does the cancer vaccine pipeline justify the valuation?
#MRNA #Biotech #Pharma
Kinda funny where $MRNA has ended up this year.
A few months ago people were still treating this like a broken, post COVID story. Now it is up over 500% year-to-date and heading straight back into the Nasdaq 100 on Oct 9.
And that actually matters beyond just the headline.
There is more than $800B sitting in products linked to the index, so once Moderna gets added a lot of passive money has to own it whether they care about the cancer vaccine story or not.
That does not change the fundamentals, obviously. But it does shift who has to be in the stock.
I am more interested now in what happens after the forced index buying is out of the way.
Especially since Citi just downgraded the stock to a Sell arguing that the recent run has pushed the pipeline valuation way past its actual net present value.
That sets up a beautiful battlefield for the next major milestone.
Once the mechanical index flows clear out, all eyes will shift to October 24 for the ESMO oncology data presentation.
That is when we get back to the real question again
How much of this move was just positioning and liquidity, and how much is the market actually willing to pay for what this oncology pipeline could become?
$MRK #Biotech #Pharma
study bitcoins retweeted
Most people only buy NVIDIA and hope for the best.
If you want a resilient AI portfolio, you need exposure across the entire stack: Compute, Storage, Cloud, and Software.
🧵 10 AI Stocks to Buy During the Dip (Categorized by Layer)
⚡ Layer 1: Compute & Processors
The raw muscle driving large-scale model training and inference.
✔NVIDIA ($NVDA) ➔ The undisputed market leader in enterprise GPU clusters and CUDA ecosystem software.
✔AMD ($AMD) ➔ Primary challenger expanding market share with MI300 series accelerators.
💾 Layer 2: Memory & High-Speed Storage
Where the massive data pipeline bottlenecks actually happen.
✔Micron Technology ($MU) ➔ Essential provider of High Bandwidth Memory (HBM3e) required for next-gen AI chips.
✔Western Digital ($WDC) ➔ High-density enterprise storage powering massive dataset training pipelines.
☁️ Layer 3: Cloud & Infrastructure Hyperscalers
The physical data centers and cloud platforms hosting AI operations.
✔Amazon ($AMZN / AWS) ➔ Dominant cloud infrastructure provider integrating custom Trainium/Inferentia silicon.
✔Hewlett Packard Enterprise ($HPE) ➔ Enterprise AI server architecture, liquid cooling, and edge compute systems.
🎮 Layer 4: Real-Time Software & Intelligence Engines
The application and runtime layer translating AI into end-user experiences.
✔Unity Software ($U) ➔ Interactive 3D engines, spatial compute, and real-time AI simulation runtimes.
(Plus additional enterprise AI application stack targets: Microsoft $MSFT, Palantir PLTR, BroadcomAVGO)
Strategy: Don't chase single-day hype spikes. Focus on foundational infrastructure plays with strong long-term fundamentals across every layer of the software to hardware pipeline.
study bitcoins retweeted
$OPTH IS BUILDING A BUSINESS AROUND REGULATED PSYCHEDELIC MEDICINE.
Optimi Health manufactures finished-dose psilocybin and MDMA capsules for regulated medical and clinical use.
→ Commercial supply already established in Australia
→ Health Canada GMP-compliant manufacturing
→ Products designed for authorized programs and clinical trials
→ Expanding its clinical and international footprint
The interesting part is that Optimi is already operating beyond the purely research-stage phase.
Paid partnership with Optimi Health.
Do your own research.
Disclaimer:
stockresearchtoday.com/opth/
study bitcoins retweeted
$OPTH (CSE:OPTI / NASDAQ:OPTH) is sitting in the final shakeout of a textbook Elliott Wave 4 correction. The chart shows a completed impulsive 1-2-3 sequence, a messy mid-range “Distribution Struggle,” and price now coiling inside a falling channel that is resolving the last (v) of 4. That setup is why the tape looks ugly today and why some traders are watching the next flush as a potential buy zone rather than a breakdown👇
Disclaimer: stockresearchtoday.com/opth/
study bitcoins retweeted
You can start your day like
1:NOEL ZAKAYO $150
2:ARJUN SHARMA $902
3:MICHAEL OSEI $707
Like a joke but this is how money made
If you think education is expensive try now ignorance
Join here & use code: REBELLION1 👇
fxcfunded.com/full-registrat…
study bitcoins retweeted
Ready to Trade With More Capital?
Trade smarter. Follow clear rules. Keep access to your profits.
@Funded_FXC offers transparent trading challenges, straightforward rules, and fast profit access designed for traders who want a structured path to funded trading.
Take the challenge. Prove your strategy. Trade with confidence. $EUROUSD
Join here & use code: REBELLION1 👇
fxcfunded.com/full-registrat…
study bitcoins retweeted
From setups → entries → exits — I’ll be posting every single day the stocks I trade.
Don’t plan to miss this.
This is where meaningful impact meets execution.
See you there.
👇 xitter.cf/RebellioMarket/creator…
